Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members

In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral SACT. To understand this, we would like to gather the views of healthcare professionals involved in cancer care, on their perspectives and experiences on brand switching of oral SACT. Insights will be combined with data from the NIHR-funded SWITCH project, to improve cancer treatment delivery.

We would be very grateful if you would complete this online survey, which will take 10-15 minutes, by scanning the QR code or through this link: https://qualtrics.ucl.ac.uk/jfe/form/SV_dj0l16wIjCFIbWe

If you have any problems please email Pinkie Chambers : [email protected]

We would like responses by November 28th

Many thanks
Jessica Lim

4th Year MPharm Student, UCL School of Pharmacy

Supervisors: Dr Pinkie Chambers, Dr Zoe Moon, Rebecca Todd

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article